MXPA01001148A - Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch - Google Patents
Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starchInfo
- Publication number
- MXPA01001148A MXPA01001148A MXPA/A/2001/001148A MXPA01001148A MXPA01001148A MX PA01001148 A MXPA01001148 A MX PA01001148A MX PA01001148 A MXPA01001148 A MX PA01001148A MX PA01001148 A MXPA01001148 A MX PA01001148A
- Authority
- MX
- Mexico
- Prior art keywords
- starch
- plant
- nucleic acid
- enzymes
- plants
- Prior art date
Links
- 229920000881 Modified starch Polymers 0.000 title claims description 19
- 235000019426 modified starch Nutrition 0.000 title claims description 19
- 239000004368 Modified starch Substances 0.000 title claims description 10
- 229920002472 Starch Polymers 0.000 claims abstract description 261
- 235000019698 starch Nutrition 0.000 claims abstract description 260
- 239000008107 starch Substances 0.000 claims abstract description 232
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 85
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 82
- 102000004190 Enzymes Human genes 0.000 claims abstract description 71
- 108090000790 Enzymes Proteins 0.000 claims abstract description 71
- 229920001850 Nucleic acid sequence Polymers 0.000 claims abstract description 52
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 13
- 239000010452 phosphate Substances 0.000 claims abstract description 13
- 241000196324 Embryophyta Species 0.000 claims description 187
- 210000004027 cells Anatomy 0.000 claims description 144
- 102000004169 proteins and genes Human genes 0.000 claims description 60
- 108090000623 proteins and genes Proteins 0.000 claims description 60
- 108090000364 Ligases Proteins 0.000 claims description 56
- 102000003960 Ligases Human genes 0.000 claims description 56
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims description 43
- 240000001016 Solanum tuberosum Species 0.000 claims description 40
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 29
- 230000015572 biosynthetic process Effects 0.000 claims description 27
- 230000000692 anti-sense Effects 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 230000002829 reduced Effects 0.000 claims description 18
- 238000003786 synthesis reaction Methods 0.000 claims description 17
- 230000002194 synthesizing Effects 0.000 claims description 17
- 229920002676 Complementary DNA Polymers 0.000 claims description 16
- 240000008042 Zea mays Species 0.000 claims description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 16
- 239000002299 complementary DNA Substances 0.000 claims description 15
- 235000005822 corn Nutrition 0.000 claims description 13
- 235000005824 corn Nutrition 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 230000001580 bacterial Effects 0.000 claims description 11
- 102000013142 Amylases Human genes 0.000 claims description 10
- 108010065511 Amylases Proteins 0.000 claims description 10
- 108091000031 Glucose-1-phosphate adenylyltransferases Proteins 0.000 claims description 10
- 210000002706 Plastids Anatomy 0.000 claims description 10
- 235000019418 amylase Nutrition 0.000 claims description 10
- 238000003860 storage Methods 0.000 claims description 10
- 229940025131 Amylases Drugs 0.000 claims description 9
- 108010043943 Starch Phosphorylase Proteins 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 229920001503 Glucan Polymers 0.000 claims description 8
- 240000008529 Triticum aestivum Species 0.000 claims description 8
- 230000001965 increased Effects 0.000 claims description 8
- 230000001105 regulatory Effects 0.000 claims description 8
- 235000021307 wheat Nutrition 0.000 claims description 8
- 101710014726 SS3 Proteins 0.000 claims description 7
- GUBGYTABKSRVRQ-ASMJPISFSA-N α-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 claims description 7
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims description 6
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims description 5
- 108010039811 EC 2.4.1.21 Proteins 0.000 claims description 5
- 108010028688 Isoamylase Proteins 0.000 claims description 5
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 5
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 102000004366 Glucosidases Human genes 0.000 claims description 3
- 108010056771 Glucosidases Proteins 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000005022 packaging material Substances 0.000 claims description 3
- 229920002477 rna polymer Polymers 0.000 claims description 2
- 108010073135 Phosphorylases Proteins 0.000 claims 2
- 102000009097 Phosphorylases Human genes 0.000 claims 2
- 230000036740 Metabolism Effects 0.000 abstract description 20
- 230000004060 metabolic process Effects 0.000 abstract description 20
- 230000035786 metabolism Effects 0.000 abstract description 20
- 239000000047 product Substances 0.000 description 23
- 230000001131 transforming Effects 0.000 description 23
- 239000000499 gel Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000008103 glucose Substances 0.000 description 14
- WMGFVAGNIYUEEP-WUYNJSITSA-N Amylopectin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)O2)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H]1O WMGFVAGNIYUEEP-WUYNJSITSA-N 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 229920000945 Amylopectin Polymers 0.000 description 11
- 239000000654 additive Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 229920000856 Amylose Polymers 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000006011 modification reaction Methods 0.000 description 10
- 229940088598 Enzyme Drugs 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- 240000006394 Sorghum bicolor Species 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 238000010353 genetic engineering Methods 0.000 description 9
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 8
- 240000004713 Pisum sativum Species 0.000 description 8
- 235000010582 Pisum sativum Nutrition 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 239000003245 coal Substances 0.000 description 8
- 230000004059 degradation Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 230000036961 partial Effects 0.000 description 8
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 7
- 230000000996 additive Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 210000001938 protoplasts Anatomy 0.000 description 7
- 210000001519 tissues Anatomy 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 229920001405 Coding region Polymers 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000002255 enzymatic Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 235000010804 Maranta arundinacea Nutrition 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N PMSF Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 5
- 101700068286 SUS2 Proteins 0.000 description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 5
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 5
- 240000006809 Thalia geniculata Species 0.000 description 5
- 235000012419 Thalia geniculata Nutrition 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive Effects 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 239000011111 cardboard Substances 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 235000012015 potatoes Nutrition 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920001059 synthetic polymer Polymers 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- 240000002791 Brassica napus Species 0.000 description 4
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- 240000000218 Cannabis sativa Species 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- -1 G 418 Chemical compound 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 240000007842 Glycine max Species 0.000 description 4
- 235000003222 Helianthus annuus Nutrition 0.000 description 4
- 240000006669 Helianthus annuus Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 235000004431 Linum usitatissimum Nutrition 0.000 description 4
- 240000006240 Linum usitatissimum Species 0.000 description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 229920000272 Oligonucleotide Polymers 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 240000005158 Phaseolus vulgaris Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000007238 Secale cereale Nutrition 0.000 description 4
- 240000002057 Secale cereale Species 0.000 description 4
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 4
- 241000219977 Vigna Species 0.000 description 4
- 235000010726 Vigna sinensis Nutrition 0.000 description 4
- 230000003115 biocidal Effects 0.000 description 4
- 235000009120 camo Nutrition 0.000 description 4
- 235000005607 chanvre indien Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000875 corresponding Effects 0.000 description 4
- 238000010192 crystallographic characterization Methods 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000001879 gelation Methods 0.000 description 4
- 239000011487 hemp Substances 0.000 description 4
- 235000012765 hemp Nutrition 0.000 description 4
- 235000012766 marijuana Nutrition 0.000 description 4
- 235000019713 millet Nutrition 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001172 regenerating Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- 239000011778 trisodium citrate Substances 0.000 description 4
- 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 description 3
- 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 description 3
- 108090000994 Catalytic RNA Proteins 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 3
- 239000004698 Polyethylene (PE) Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 108010029485 Protein Isoforms Proteins 0.000 description 3
- 102000001708 Protein Isoforms Human genes 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 240000004922 Vigna radiata Species 0.000 description 3
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 3
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 3
- 241000625014 Vir Species 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 230000024126 agglutination involved in conjugation with cellular fusion Effects 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 150000004676 glycans Polymers 0.000 description 3
- 229920000578 graft polymer Polymers 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 media Substances 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000717 retained Effects 0.000 description 3
- 229920002033 ribozyme Polymers 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000002195 soluble material Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- GPRBEKHLDVQUJE-VINNURBNSA-N Cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 2
- 229940088530 Claforan Drugs 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 210000000172 Cytosol Anatomy 0.000 description 2
- 239000001653 FEMA 3120 Substances 0.000 description 2
- 102100005993 G6PD Human genes 0.000 description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 210000003470 Mitochondria Anatomy 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 101700082982 PAT0 Proteins 0.000 description 2
- 241001364096 Pachycephalidae Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000003934 Vacuoles Anatomy 0.000 description 2
- 240000004137 Yucca aloifolia Species 0.000 description 2
- 235000004552 Yucca aloifolia Nutrition 0.000 description 2
- 235000012044 Yucca brevifolia Nutrition 0.000 description 2
- 235000017049 Yucca glauca Nutrition 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037348 biosynthesis Effects 0.000 description 2
- 239000004566 building material Substances 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000005712 crystallization Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000003247 decreasing Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000011087 paperboard Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 108010048769 pullulanase Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 101700069822 sus1 Proteins 0.000 description 2
- 230000002522 swelling Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 125000002306 tributylsilyl group Chemical group C(CCC)[Si](CCCC)(CCCC)* 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-Phaseollin Natural products C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-Naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- WFPZSXYXPSUOPY-ROYWQJLOSA-L ADP α-D-glucoside(2-) Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP([O-])(=O)OP([O-])(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-L 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 229960001561 Bleomycin Drugs 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 210000003763 Chloroplasts Anatomy 0.000 description 1
- 101700011961 DPOM Proteins 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-K Disodium phosphate Chemical compound [Na+].[Na+].[O-]P([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-K 0.000 description 1
- 101700061856 FHL2 Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 229940045189 Glucose-6-Phosphate Drugs 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N Glucose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108020002022 Hexokinases Proteins 0.000 description 1
- 102000005548 Hexokinases Human genes 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 101710029649 MDV043 Proteins 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 239000004594 Masterbatch (MB) Substances 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 101710010904 PCBD2 Proteins 0.000 description 1
- 101700061424 POLB Proteins 0.000 description 1
- OFWYIUYVHYPQNX-JXFKEZNVSA-N Phaseollidin Chemical compound OC1=CC=C2[C@@H]3OC4=C(CC=C(C)C)C(O)=CC=C4[C@@H]3COC2=C1 OFWYIUYVHYPQNX-JXFKEZNVSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 101700054624 RF1 Proteins 0.000 description 1
- 229940100486 RICE STARCH Drugs 0.000 description 1
- 108020004412 RNA 3' Polyadenylation Signals Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 210000002356 Skeleton Anatomy 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L Sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 239000004826 Synthetic adhesive Substances 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N Thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 229920001949 Transfer RNA Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical group [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102400000757 Ubiquitin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940100445 WHEAT STARCH Drugs 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 244000150668 Zea mays subsp mays Species 0.000 description 1
- 229940023877 Zeatin Drugs 0.000 description 1
- 229940093612 Zein Drugs 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- ZKJOXOJMGXFSPF-QYZPTAICSA-N [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;hydrate Chemical compound O.NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 ZKJOXOJMGXFSPF-QYZPTAICSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 230000004523 agglutinating Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000003281 allosteric Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229920002847 antisense RNA Polymers 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000002860 competitive Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000003628 erosive Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal Effects 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 101710010895 glpV Proteins 0.000 description 1
- 108010004047 granule-bound starch synthase I Proteins 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229940094991 herring sperm DNA Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000001050 lubricating Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005020 pharmaceutical industry Methods 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000865 phosphorylative Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000023 polynucleotide Polymers 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000011395 ready-mix concrete Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003362 replicative Effects 0.000 description 1
- 108091007521 restriction endonucleases Proteins 0.000 description 1
- 230000000979 retarding Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000009988 textile finishing Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229930007823 thymol Natural products 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 200000000019 wound Diseases 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
Abstract
The invention relates to recombinant nucleic acid molecules containing two or more nucleotide sequences which code enzymes involved in the metabolism of starch. The invention also relates to methods for producing transgenic plant cells and plants which synthesize a starch that is modified with regard to the phosphate content and side-chain structure thereof. In addition, the invention relates to vectors and host cells which contain the inventive nucleic acid molecules, to the plant cells and plants produced using the inventive methods, to the starch which is synthesized by the inventive plant cells and plants, and to methods for producing this starch.
Description
PLANTS THAT SYNTHESIZE A MODIFIED STARCH, METHODS TO PRODUCE THESE PLANTS. YOUR USE, AND MODIFIED STARCH
FIELD OF THE INVENTION
The present invention relates to recombinant nucleic acid molecules that contain two or more nucleotide sequences that encode enzymes involved in starch metabolism; to procedures for generating transgenic cells and plants that synthesize modified starch with respect to its phosphate content and its side chain structure. In addition, the present invention relates to vectors and host cells that contain the nucleic acid molecules according to the invention; to cells and plants that originate from the methods according to the invention; to the starch synthesized by the cells and plants according to the invention; and to processes for the preparation of this starch.
BACKGROUND OF THE INVENTION
Taking into account the growing importance of plant constituents as renewable resources, biotechnological research attempts to adapt raw materials to the demands of the processing industry. In this way, to make possible the use of renewable resources in as many fields of application as possible, it is necessary to make available a wide variety of materials. In addition to oils, fats and proteins, the 5 polysaccharides are also important renewable resources of plants. Not only cellulose takes a primordial position in polysaccharides, but also starch, which is one of the most important storage substances in higher plants. In addition to corn, rice and wheat, the potato also plays an important role in particular in the production of starch. 10 The polysaccharide starch is a polymer of chemically uniform units, the glucose molecules. However, it is a very complex mixture of different forms of molecules that differ with respect to their degree of polymerization and the occurrence of ramifications in the glucose chains. Therefore, starch is not a raw material
uniform. In particular, a difference is made between amylose starch, an essentially unbranched polymer of glucose molecules with -1,4-glycosidic bonds, and amylopectin starch which in turn constitutes a complex mixture of branched glucose chains differently. Other branches are generated by the presence of -1, 6-glycosidic bonds
additional. In typical plants used for the production of starch, such as for example corn or potato, the synthesized starch consists of about 25% amylose starch and about 75% amylopectin starch.
^^ ¡g ffigj «te ^ ¿^ ^^^^ gjil | j¡g ^^ -? gttea ^^^ ^^ | The molecular structure of the starch, determined mainly by the degree of branching, the amylose / amylopectin ratio, the average length and distribution of the side chains, and the presence of phosphate groups, are of paramount importance for the important functional properties in starch and its aqueous solutions, respectively. Important functional properties that must be mentioned are, for example, solubility, degradation behavior, film-forming properties, viscosity, color stability, gelation properties and binding and adhesion properties. For several applications,
The granule size of the starch may also be important. Also, for certain applications, the production of high amylose starches is of particular interest. In addition, a modified starch contained in the cells of a plant can advantageously alter the behavior of said cells under certain conditions. For example, it is feasible to reduce
degradation of starch during the storage of starch-containing organs such as, for example, seeds or tubers, before processing, for example before starch extraction. It is also of interest to produce modified starches that make cells or plant organs that contain such starch, more suitable for processing,
for example in the preparation of food products such as popcorn or corn flakes, or slices, chips or potato powder. Of particular interest is the improvement of starches with respect to decreased cold sweetening, ie, decreased release of reducing sugars (in
particular glucose) by prolonged storage at low temperatures. It is common to store potatoes especially at temperatures of 4 to 8 ° C to reduce the degradation of starch during storage. The sugars released during this process, in particular glucose, result in undesirable browning reactions during the production of slices or potato chips (what are referred to as the Maillard reactions). The starch that can be isolated from plants is often adapted for particular industrial purposes with the help of chemical modifications that require, as a rule, time and money. For the
Therefore, it seems convenient to find possibilities to generate plants that synthesize a starch whose properties already meet the specific demands of the processing industry and thus combine the economic and ecological advantages. One possibility of producing such plants, in addition to
measures of reproduction, is the direct genetic alteration of the starch metabolism of starch-producing plants, by means of genetic engineering methods. However, a prerequisite for the same is the identification and characterization of the enzymes involved in the modification of starch synthesis and in the degradation of starch.
(starch metabolism), and the isolation of the corresponding DNA sequences encoding these enzymes. The biochemical pathways leading to the synthesis of starch are essentially known. In plant cells, the synthesis of starch
It takes place in the plastids. In photosynthetically active tissues, these plastids are chloroplasts; In photosynthetically inactive starch storage tissues, they are the amyloplasts. Important enzymes involved in the synthesis of starch are, for example, branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases, debranching enzymes, disproportionate enzymes, plastid starch phosphorylases, and R1 enzymes ( R1 proteins).
BRIEF DESCRIPTION OF THE INVENTION
An object of the present invention is to provide different or alternative genetic engineering methods for modifying starch metabolism in starch-synthesizing plants (e.g., rye, barley, oats, corn, wheat, sorghum and millet, sago, rice, peas, large-leaved pea, yucca, potato, tomato, oilseed rape, soybeans, hemp, flax, sunflower, cowpea, mung beans, beans, plantain or arrowroot), or suitable nucleic acid molecules, by means of which cells can be transformed plants to allow the synthesis of starch varieties advantageously altered. Said altered starch varieties exhibit, for example, modifications with respect to their degree of branching, the amylose / amylopectin ratio, the phosphate content, the granule size of
^ A ^^ & * ^^^^^^^^ g ^ starch and / or the average length and distribution of the side chains (ie, the structure of the side chain). A further object of the present invention is to provide methods that allow the generation of transgenic plants that synthesize a variety of altered (modified) starch. Surprisingly, the transgenic plants or cells that have been transformed with the nucleic acid molecules of the invention, or to be used according to the invention, synthesize a starch that is altered in the particular manner that is described in the invention with regarding its physicochemical properties and / or the structure of its side chain. In contrast, known starches that are synthesized by transgenic plants do not exhibit the alterations according to the invention. In accordance with the invention, these objects are achieved using the forms specified in the claims.
DETAILED DESCRIPTION OF THE INVENTION
Therefore, the present invention relates to a recombinant nucleic acid molecule (nucleotide sequence) comprising: (a) at least one nucleotide sequence (polynucleotide or nucleic acid molecule) that encodes a protein with the function of a soluble starch III synthetase, or fragments of said nucleotide sequence; and (b) one or more nucleotide sequences encoding a protein selected from group A, which consists of proteins that function as branching enzymes (BE I, lia and llb), ADP glucose pyrophosphorylases, starch synthetases linked to granule, soluble starch synthetases I, II, or other, debranching enzymes, disproportionate enzymes, plastid starch phosphorylases, R1 enzymes, amylases and glycosidases; or fragments thereof - preferably synthetases of soluble starch II, soluble starch synthetases I and / or branching enzymes, and fragments thereof; and nucleic acid molecules that hybridize to one of said nucleotide sequences or fragments thereof, preferably a deoxyribonucleic acid molecule or a ribonucleic acid molecule, especially a cDNA molecule. Especially preferred is a nucleic acid molecule that hybridizes specifically with one of said nucleotide sequences or fragments thereof. Nucleotide sequences which are suitable according to the invention, and which encode a protein having the function of a soluble starch synthetase III, are described, for example, in EP-A-0779363. For the purposes of this invention, it is understood that the term "nucleotide sequence encoding a protein having the function of a soluble starch synthetase III" means in particular sequences whose coding region has a length of 3000-4500 bp, preferably 3200-4250 bp, especially 3400-4000 bp, and whose homology with the entire coding region of a nucleic acid encoding
a protein having the function of a starch synthetase amounts to at least 70%, preferably at least 80%, especially at least 90%, and most preferably at least 95%. Nucleotide sequences which are suitable in accordance with the invention, and which encode a group A protein, are for example soluble starch synthetases (type I, II or other) or granule-linked starch synthetase isoforms (e.g. , Hergersberg, 1988, thesis for PhD, University of Cologne, Abel, 1995, thesis for PhD, FU Berlin, Abel et al, 1996, Plant Journal 10 (6): 981-991, Visser and others, 1989, Plant Sci. ,
64: 185-192; van der Leij et al., 1991, Mol. Gen. Genet. 228: 240-248; EP-A-0779363; WO 92/11376; WO 96/15248, in which SSSB is a soluble starch synthetase I and GBSSII is a soluble starch II synthetase; WO 97/26362; WO 97/44472; WO 97/45545; Delrue et al., 1992, J. Bacteriol. 174: 3612-3620; Baba et al., 1993, Plant Physiol. 103: 565-573; Dry and others,
1992, The Plant Journal 2, 2: 193-202, or in the EMBL X74160 database entries; X58453; X88789); Branching enzyme sophomores (branching enzymes I, Na, llb), debranching enzyme isoforms (debranching enzymes, isoamylases, pullulanases) or disproportionation enzyme sophorms, which are described for example in WO 92/14827; WO
95/07335; WO 95/09922; WO 96/19581; WO 97/22703; WO 97/32985; WO 97/42328; Takaha et al., 1993, J. Biol. Chem., 268: 1391-1396, or in the EMBL X83969 database entry, and those for ADP glucose pyrophosphorylases, plastid starch phosphorylase isoforms and R1 enzymes
¿^ ^^^ Ü * l > i ^^^? fefeeS < ifc | (R1 proteins), which are described, for example, in EP-A-0368506; EP-A-0455316; WO 94/28146; DE 19653176.4; WO 97/11188; Brisson et al., 1989, The Plant Cell 1: 559-566; Buchner et al., 1996, Planta 199: 64-73; Camirand et al., 1989, Plant Physiol. 89 (Suppl 4) 61; Bhatt & Knowler, J. 5 Exp. Botany 41 (suppl.) 5-7; Lin et al., 1991, Plant Physiol. 95: 1250-1253; Sonnewald et al., 1995, Plant Mol. Biol. 27: 567-576; DDBJ No. D23280; Lorberth et al., 1998, Nature Biotechnology, 16: 473-477, and also for amylases and glucosidases. The nucleotide sequences that are used properly
In accordance with the invention, they are of prokaryotic or eukaryotic origin, preferably of bacterial, fungal or vegetable origin. For the purposes of the present invention, the term "fragment" denotes portions of the nucleic acid molecules according to the invention, or that are used according to the invention, which have a
length of at least 15 bp, preferably at least 150 bp, especially preferably at least 500 bp, but whose length is generally not greater than 5000 bp, preferably 2500 bp. For the purposes of the present invention, "hybridization" denotes a hybridization under conventional hybridization conditions, preferably
under severe conditions such as those described by Sambrook et al., "Molecular Cloning, A Laboratory Manual" [Molecular Cloning, Laboratory Manual] 2nd. Edition (1989) Cold Spring Harbor Laboratory Press, Cold
^^^^^^ ^^^^^^ rfsstó ^^^^^^^ Spring Harbor, New York). In particular, the term "fragment" comprises biologically active molecules. It is especially preferred that a "specific hybridization" take place under the following very severe hybridization conditions: Hybridization buffer: SSC 2x; solution
Denhardt 10x (Ficoll 400 + PEG + BSA, ratio 1: 1: 1); SDS 0.1%, EDTA 5 mM; 50 mM Na2HPO4; Herring sperm DNA 250 g / ml; TRNA 50 g / ml; or 0.25 M sodium phosphate buffer solution pH 7.2; 1 mM EDTA; SDS 7%; at 10 Hybridization temperature T = 55 at 68 ° C, Wash buffer: 0.2x SSC; SDS 0.1% and Washing temperature: T = 40 to 68 ° C. Molecules that hybridize with the nucleic acid molecules according to the invention, or that are used in accordance with
The invention also encompasses fragments, derivatives and allelic variants of the nucleic acid molecules according to the invention or which are used according to the invention. It is understood that "fragments" mean not only portions of the nucleic acid molecules that are long enough to encode a functionally active portion of the proteins that
2nd are described. Within the context of the present invention, the term
"derivative" means that the sequences of these molecules differ from the nucleic acid sequences according to the invention, or that they are used according to the invention, in one or more positions, and exhibit a high
^ k5 ^^ á * i j! ^ 'degree of homology with these sequences. Homology means a sequential identity of at least 60%, preferably more than 70%, and especially more than 85%, in particular more than 90%, and most preferably more than 95%. Deviations from the nucleic acid molecules according to the invention, or which are used according to the invention, can be originated by means of one or more deletions, substitutions, insertions (addition) or recombinations. In addition, homology means that there is a functional and / or structural equivalence between the nucleic acid molecules in question and the proteins encoded by them. The nucleic acid molecules which are homologous to the molecules according to the invention, or which are used according to the invention, and which constitute derivatives of these molecules, are as a rule variations of these molecules which constitute modifications which exert a biological function the same, virtually identical or similar. They can be variations of natural occurrence, for example sequences of other plant species, or mutations, it being possible that these mutations occur naturally or have been introduced by directed mutagenesis. The variations can also be synthetic sequences. Allelic variants may be naturally occurring variants or synthetic variants or variants generated by recombinant DNA technology. The nucleic acid molecules according to the invention, or used according to the invention, can be DNA molecules, in particular cDNA molecules or, if appropriate, the combination of genomic molecules. In addition, the nucleic acid molecules according to the invention, or which are used according to the invention, can be RNA molecules. The nucleic acid molecules according to the invention, or which are used according to the invention, or fragments thereof, can be obtained, for example, from natural sources, or they can be generated by means of recombinant technology or can be generate by synthesis. To express the nucleic acid molecules according to the invention, or used according to the invention, in sense or antisense orientation in plant cells, they bind to DNA regulatory elements that ensure transcription in plant cells. These include, in particular, promoters. In general, any promoter that is active in plant cells is suitable for expression. The promoter can be chosen in such a way that the expression is constitutive or is only in a particular tissue, at a particular time point of the development of the plant, or at a point of time determined by external factors that may be, for example, inducible chemically or biologically. With respect to the transformed plant, the promoter can be homologous or heterologous, as can the nucleotide sequence. Examples of suitable promoters are the 35S RNA promoter of cauliflower mosaic virus, and the corn ubiquitin promoter, for constitutive expression; the B33 patatin promoter (Rocha-Sosa et al., 1989 EMBO J. 8: 23-29) for tuber-specific expression in potatoes, or a promoter that ensures expression only in photosynthetically active tissues, for example the ST-LS1 promoter (Stockhaus et al., 1987, Proc. Nati, Acad. Sci., USA 84: 7943-7947, Stockhaus et al., 1989, EMBO J. 8: 2445-2451); the Ca / b promoter (for example, U.S. Patent Nos. 5656496, 5639952, Bansal et al., 1992, Proc. Nati. Acad. Sci. USA, 89: 3654-3658), and the Rubsico SSU promoter (see, for example, for example, U.S. Patent Nos. 5034322 and 4962028), or a specific endosperm expression of the glutelin promoter (Leisy et al., Plant Mol. Biol. 14 81990), 41-50; Zheng et al., Plant J. 4 (1993), 357-366; Yoshihara et al., FEBS Lett, 383 (1996) 213-218), the shrunken-1 promoter (Werr et al., EMBO J. 4 (1985), 1373-1380), the wheat HMG promoter, the USP promoter, the phaseolin promoter, or promoters of maize zein genes (Pedersen et al., Cell 29 (1982), 1015-1026; Quatroccio et al., Plant Mol. Biol. 15 (1990), 81-93). A terminator sequence terminating the nucleic acid molecule according to the invention can serve to correctly end the transcription, and to help transcribe a tail of poly-A, which is considered to have the function of stabilizing the transcripts. These elements have been described in the literature (see Gielen et al., 1989, EMBO J. 8: 23-29) and as a rule, they are interchangeable as desired. The nucleic acid molecules according to the invention, or used according to the invention, can be used to generate transgenic cells and plants that show increase and / or reduction of the activity of the soluble starch synthetase III and at least a
additional enzyme of starch metabolism. For this purpose, the nucleic acid molecules according to the invention, or used according to the invention, are introduced into suitable vectors, provided with the nucleic acid regulatory sequences that are necessary for efficient transcription in plant cells, and enter the plant cells. On the one hand, there is the possibility of using the nucleic acid molecules according to the invention, or used according to the invention, to inhibit the synthesis of endogenous soluble starch III synthesis and / or at least one additional protein of group A in the cells. This can be achieved with the help of antisense constructs, in vivo mutagenesis, a cosuppression effect that occurs, or with the help of properly constructed ribozymes. On the other hand, the nucleic acid molecules according to the invention, or used according to the invention, can be used to express the soluble starch synthetase III and / or at least one additional group A protein, in cells of transgenic plants, and thus lead to a greater activity, in the cells, of the enzymes that have been expressed in each case. In addition, there is the possibility of using the molecules according to the invention, or that are used according to the invention, to inhibit the synthesis of the endogenous soluble starch III synthetase and the overexpression of at least one additional protein of group A in the cells. Finally, the nucleic acid molecules according to the invention, or used according to the invention, can also be used
h ¿^^^? %to? > s ^ e * - ^ ^ i X ...- to express the soluble starch synthetase III and to inhibit at least one additional group A protein in cells of transgenic plants. The last two mentioned embodiments of the invention thus lead, in the cells, to a simultaneous inhibition and increase in the activity of the enzymes that are inhibited or expressed, respectively. The invention further relates to a vector comprising a nucleic acid molecule according to the invention. The term "vector" encompasses plasmids, cosmids, viruses, bacteriophages and other vectors conventionally used in genetic engineering, which contain the nucleic acid molecules according to the invention and which are suitable for transforming cells. Preferably, such vectors are suitable for transforming plant cells. Preferably, they allow the integration of the nucleic acid molecules according to the invention, if appropriate together with flanking regulatory regions, into the genome of the plant cell. Examples are binary vectors such as pBinAR or pBinB33, which can be used in gene transfer mediated by agrobacteria. In a preferred embodiment, the vector according to the invention is distinguished by the fact that the nucleotide sequence encoding a protein having the function of a soluble starch synthetase III or fragments thereof, is present in sense orientation or antisense.
In a further preferred embodiment, the vector according to the invention is distinguished by the fact that the nucleotide sequence encoding one or more proteins selected from group A or fragments thereof is present in sense or antisense orientation. In another preferred embodiment, the vector according to the invention is distinguished by the fact that the nucleotide sequence encoding a plurality of proteins selected from group A or fragments thereof, is partially in sense orientation and partially in orientation of antisense Preferably, the vector according to the invention comprises one or more regulatory elements that ensure the transcription and synthesis of an RNA in a prokaryotic or eukaryotic cell. In addition, by means of the usual techniques of Molecular Biology (see for example Sambrook and others, 1989, "Molecular Cloning, A Laboratory Manual" [Molecular Cloning, Laboratory Manual] 2nd. Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York), it is possible to introduce several mutations into the DNA sequences according to the invention, or to be used according to the invention, which leads to the synthesis of proteins with biological properties that can be altered. On the one hand, it is possible to generate deletion mutants in which sequences are generated, by progressive deletions from the 5 'end or from the 3' end of the coding DNA sequences, which lead to the synthesis of analogously truncated proteins.
For example, such deletions at the 5 'end of the DNA sequence allow directed production of enzymes which, due to the removal of the relevant transit or signal sequences, are no longer located in their original compartment (homolog), but in the cytosol, or which, due to the addition of other signal sequences, are located in one or more other compartments (heterologous) (eg plasto, vacuole, mitochondria, apoplast). On the other hand, it is also possible to introduce point mutations at positions where an altered amino acid sequence affects, for example, the activity of the enzyme or the regulation of the enzyme. In this way, it is possible to generate for example mutants that have an altered value of KM or Kcat, or that are no longer subject to the regulatory mechanisms normally present in the cell, for example by allosteric regulation or covalent modification. For manipulation of genetic engineering in prokaryotic cells, the DNA sequences according to the invention, or used according to the invention, or fragments of these sequences, can be introduced into plasmids that allow mutagenesis or a sequence altered by the recombination of DNA sequences. Base exchanges can be made or natural or synthetic sequences can be added, with the help of normal methods of Molecular Biology (see Sambrook et al., 1989, in the aforementioned place). To link the DNA portions with one another, adapters or linkers can be fixed in the portions. In addition, manipulations that provide adequate restriction cleavage sites or that remove excessive DNA or restriction cleavage sites that are no longer needed may be employed. Where insertions, deletions or substitutions are required, in vitro mutagenesis, initiator repair, restriction or ligation can be employed. The analytical methods that are generally carried out are sequence analysis, restriction analysis and, if appropriate, other methods of Biochemistry and Molecular Biology. The invention also relates to a transgenic host cell with altered metabolism of starch, in particular to prokaryotic or eukaryotic cells, preferably bacterial or plant cells (monocotyledonous or dicotyledonous) (for example E. coli, Agrobacterium, Solananceae, Poideae, rye, barley , oats, corn, wheat, sorghum and millet, sago, rice, peas, large-seeded peas, cassava, potatoes, tomatoes, oilseed rape, soybeans, hemp, flax, sunflower, cowpeas, mung beans, beans, plantains or arrowroot) containing one or more nucleic acid molecules according to the invention or one or more vectors according to the invention, or derived from said cell. Another subject of the invention is a transgenic host cell with altered starch metabolism, in particular prokaryotic or eukaryotic cells, preferably bacterial or plant cells (e.g. E. coli, Agrobacterium, Solananceae, Poideae, rye, barley, oats, corn, wheat) , sorghum and millet, sago, rice, peas, large-leaved pea, cassava, potato, tomato, oilseed rape, soybeans, hemp, flax, sunflower, cowpea, beans
Jindm? TiA mung, bean, banana or arrowroot), which contain (a) at least one nucleotide sequence encoding a protein having the function of a soluble starch synthetase III or fragments thereof, and (b) a or more nucleotide sequences encoding a protein selected from group A or fragments thereof, or nucleotide sequences which hybridize with these nucleic acid molecules, or which derive from said cell. The host cells according to the invention can be generated not only by using the nucleic acid molecules according to the invention, but also by means of successive transformation (for example, the so-called "super-transformation"), using a plurality of portions of the nucleotide sequence according to the invention, or a plurality of vectors comprising portions of the nucleotide sequence according to the invention, which encode a protein having the function of a soluble starch synthetase III or fragments thereof and, in addition, one or more proteins selected from the Group A, consisting of branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases I, II or other debranching enzymes, disproportionate enzymes, plasmoxylated starch phosphorylases, amylases, glycosidases, R1 enzymes, fragments of the same - preferably synthetases of soluble starch II, soluble starch synthetases I and / or branching enzymes and also fragments thereof - and nucleic acid molecules that hybridize with one of said nucleotide sequences or fragments thereof, in a plurality of steps of cell transformation. Here, the cell is transformed (a) with at least one nucleic acid molecule encoding a protein having the function of a soluble starch synthetase III, its fragment, or with a vector comprising said nucleic acid molecule, and (b) is transformed simultaneously or in succession with one or more nucleic acid molecules that encode a protein that is selected from group A, consisting of branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases I , II or other debranching enzymes, disproportionate enzymes, amylases, glycosidases, plasto starch phosphorylases and R1 enzymes, or fragments thereof - preferably soluble starch synthetases II, soluble starch synthetases I and / or branching enzymes and their fragments - , and nucleic acid molecules that hybridize with one of said nucleotide sequences or fragments thereof, or one or more vectors that co They comprise one or more of said nucleic acid molecules in any desired sequence. A further subject of the invention is a process for the production of a host cell, a bacterial cell, a plant cell or a transgenic plant, which synthesize a modified starch, where they are integrated into the genome of a cell (a) at minus one nucleic acid molecule encoding a protein having the function of a soluble starch synthetase III or fragments thereof, and (b) one or more nucleic acid molecules encoding a protein selected from group A, consisting of branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases I, II or others, debranching enzymes, disproportioning enzymes, amylases, glycosidases, plasmid starch phosphorylases and R1 enzymes, or fragments thereof - preferably soluble starch synthetases II, soluble starch synthetases I and / or branching enzymes and fragments thereof, and nucleic acid hybridizing with one of said nucleotide sequences or fragments thereof; and optionally a complete plant of the transgenic plant cell is regenerated. A further embodiment of the present invention relates to a method for generating a host cell, a bacterial cell, a plant cell or a transgenic plant that synthesizes a modified starch, comprising integrating one or more nucleic acid molecules according to the invention. , or one or more vectors according to the invention, in the genome of a cell, and optionally regenerating a whole plant of the transgenic plant cell. By providing the nucleic acid molecules according to the invention, it becomes possible to take part in the metabolism of the starch of the plants, with the help of genetic engineering methods, and to alter it in such a way as to obtain as a result the synthesis of a starch. modified which is altered with respect to the starch synthesized in wild-type plants for example in terms of structure, water content, protein content, lipid content, fiber content, ash / phosphate content, amylose / amylopectin ratio, distribution of molecular mass, degree of branching, granule size, granule shape and crystallization, or in their physicochemical properties such as flowability and absorption behavior, gelation temperature, viscosity, thickener capacity, solubility, gel structure, transparency, thermal stability , stability against shear stress, stability against acids, tendency to suffer degradation dation, gelation, freeze-thaw stability, complex formation, iodine binding, film formation, adhesion power, stability against enzyme, susceptibility to digestion and reactivity. There is also the possibility of increasing production in plants properly constructed by genetic engineering, increasing the activity of proteins that are involved in the metabolism of starch, for example by overexpressing suitable nucleic acid molecules, or by providing mutants that are no longer subject to regulatory mechanisms of the cell, and / or that exhibit different temperature dependencies with respect to its activity. A particularly pronounced increase in production may be the result of increased activity of one or more proteins that are involved in the metabolism of starch in specific cells of the starch storage tissues of the transformed plants, such as, for example, in the tuber in the case of potatoes, or in the endosperm in the case of corn or wheat. The economic importance and the advantages of these possibilities of taking part in the metabolism of the starch, are enormous.
.tfmVm &fStmmi When the nucleic acid molecules according to the invention are expressed in plants, or which are used according to the invention, it is possible in principle that the synthesized protein is located in any desired cell compartment of the plant . To achieve localization 5 in a particular compartment (cytosol, vacuole, apoplast, plastids, mitochondria), if necessary, the transit or signal sequence that ensures the location must be suppressed (or removed) and, if necessary, the The rest of the coding region must be linked to DNA sequences that ensure localization in the particular compartment. These sequences are
known (see, for example, Braun et al., EMBO J: 11 (1992), 3219-3227; Wolter et al., Proc. Nati, Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al. Plant J. (1991), 95-106). The localization in certain parts of plants or tissues can be ensured, for example, by specific promoters that are well known to the person skilled in the art. The generation of plant cells with reduced activity of a protein involved in starch metabolism can be achieved, for example, by expressing an appropriate antisense RNA, a sense RNA to achieve a cosuppression effect, by mutagenesis in vivo, or expressing a properly constructed ribozim that cuts specifically
transcripts that encode one of the proteins involved in the metabolism of starch, using a nucleic acid molecule according to the invention; preferably expressing an antisense transcript.
For this purpose, it is possible to use, on the one hand, a DNA molecule that encompasses the entire sequence encoding a protein involved in the metabolism of the starch, including any flanking sequences that may be present, and also DNA molecules that only comprise 5 portions of the coding sequence, these portions having a minimum length of 15 bp, preferably at least 100-500 bp, in particular more than 500 bp. As a rule, DNA molecules are used that are shorter than 5000 bp, preferably shorter than 2500 bp. It is also possible to use DNA sequences that exhibit a high
degree of homology with the sequences of the DNA molecules according to the invention, but they are not completely identical to them. The homology minimum must be greater than about 65%. In particular, it is preferred to use sequences with a homology of about 75 to 85%, particularly about 85 to 95%. The expression of ribozymes to reduce the activity of specific proteins in cells is known in the art and is described for example in EP-B1-0 321 201. The expression of ribozymes in plant cells was described, for example, by Feyter et al. (Mol. Gen. Genet, 250 (1996), 329-338) The proteins involved in the metabolism of starch can also be reduced in plant cells according to the invention by means of the so-called "mutagenesis in". vivo ", where a hybrid RNA-DNA-oligonucleotide is introduced into cells
s,. ~ . -. , tntMa i »-, and« -ase, sas ut} .
("quimeroplasto") to transform them (Kipp PB and others, Poster Session in the 5th International Congress of Plant Molecular Biology, September 21-27, 1997, Singapore, RA Dixon and CJ Arntzen, Report of the Meeting on Metabolic Engineering in Transgenic Plants, Keystone Symposium, Copper Mountain, Colorado, USA, TIBTECH 15 (1997), 441-447, International Patent Application WO 95/15972, Kren et al, Hepatology 25 (1997), 1462-1468, Cole-Strauss and others, Science 273 81996), 1386-1389). A portion of the DNA component of the RNA-DNA-oligonucleotide used for this purpose is homologous to a nucleic acid sequence of an endogenous protein, but exhibits a mutation with respect to the nucleic acid sequence of the endogenous protein, or contains a heterologous region included by the homologous regions. The base pairing between the homologous regions of the RNA-DNA-oligonucleotide and the endogenous nucleic acid molecule, followed by homologous recombination, allows the mutation or heterologous region contained in the DNA component of the RNA-DNA-oligonucleotide to be transferred to the genome of a plant cell. This leads to reduced activity of the protein involved in starch metabolism. Alternatively, enzymatic activities involved in starch metabolism of plant cells can be reduced by means of a cosuppression effect. This method is described, for example, by Jorgensen (Trends Biotechnol., 8 (1990), 340-344), Niebel et al. (Curr. Top, Microbiol.Immunol., 197 81995), 91-103), Flavell, et al. (Curr. Top Microbiol Immunol.
& -? # c "&" - 197 (1995), 43-46), Palaqui and Vaucheret (Plant Mol. Biol. 29 81995), 149-159), Vaucheret et al. (Mol. Gen. Genet. 248 (1995), 311-317), de Borne et al. (Mol. Gen. Genet 243 (1994), 613-621). To inhibit the synthesis in transformed plants of a plurality of enzymes involved in the biosynthesis of starch, it is possible to use DNA molecules for transformation, which contain simultaneously, in antisense orientation and under the control of a suitable promoter, a plurality of regions. which encode the relevant enzymes. Each sequence may be under the control of its promoter or, alternatively, the sequences may be transcribed by a binding promoter as a fusion, so that the synthesis of the proteins in question is inhibited at approximately the same level or at a different level. With respect to the length of the individual coding regions that are used in such a construction, what has already been mentioned above for the generation of antisense constructions is also applied here. In principle, there is no upper limit for the number of antisense fragments transcribed starting from a promoter in such a DNA molecule. However, as a rule, the resulting transcript should not exceed a length of 25 kb, preferably 15 kb. Therefore, the nucleic acid molecules according to the invention, or that are used according to the invention, make it possible to transform plant cells and simultaneously inhibit the synthesis of a plurality of enzymes.
In addition, it is possible to introduce the nucleic acid molecules according to the invention, or that are used according to the invention, into traditional mutants that are deficient or defective with respect to one or more genes of starch biosynthesis (Shannon and Garwood , 1984, in Whistler, BeMiller and Paschall, "Starch: Chemistry and Technology" [Starch: Chemistry and Technology], Academic Press, London, 2nd Edition, 25-86). These defects may be related, for example, to the following proteins: cell-bound starch synthetase (GBSSI) and soluble starch synthetases (SS I, II, III and others), branching enzymes (BE I, lia and 11 Ib) , debranching enzymes (R enzymes, isoamylases, pullulanases), disproportionate enzymes and plasto starch phosphorylases. In this manner, the present invention also relates to transgenic plant cells which are obtained by means of a process according to the invention, which have been transformed with a vector or nucleic acid molecule according to the invention, or which are used according to the invention, and to plant cells or transgenic plants derived from said transformed cells. The cells according to the invention contain one or more nucleic acid molecules according to the invention, or which are used according to the invention, these being preferably linked with one or more DNA regulatory elements (eg promoter, enhancer, terminator) that ensure transcription in plant cells, in particular a promoter. The cells according to the invention can be distinguished from naturally occurring plant cells, inter alia, by the fact that they contain a nucleic acid molecule according to the invention, which does not occur naturally in these cells; or by the fact that said molecule exists integrated in a site in the genome of the cell in which it would not appear otherwise, that is, in a different genomic medium. In addition, the transgenic plant cells according to the invention can be distinguished from plant cells of natural occurrence, by the fact that they contain at least one copy of a nucleic acid molecule according to the invention, stably integrated in its genome, if appropriate, in addition to copies of such a molecule that occur naturally in the cells or nucleic acid molecules to be used in accordance with the invention. If the molecule or nucleic acid molecules introduced into the cell (s), are additional copies of those already occurring naturally in the cells, then the plant cells according to the invention can be distinguished from naturally occurring plant cells, in particular by the fact that this additional copy, or these additional copies, they are located in genome sites where they would not occur naturally, or do not occur naturally. This can be reviewed, for example, with the help of a Southern blot analysis. Preferred plant cells according to the invention are those in which the enzymatic activity of the individual enzymes involved in the metabolism of the starch is increased and / or reduced in each case by at least 10%, preferably by at least 30%. %, and especially at least 50%. Furthermore, preferably, the plant cells according to the invention can be distinguished from natural plant cells by at least one of the following characteristics: if the nucleic acid molecule that has been introduced is heterologous with respect to the plant cell, the cells Transgenic plants display the transcripts of the nucleic acid molecules according to the invention that have been introduced. These can be detected, for example, by Northern blot analysis. For example, plant cells according to the invention contain one or more proteins encoded by a nucleic acid molecule according to the invention, or used according to the invention, which has been introduced. This can be detected, for example, by immunological methods, in particular by means of a Western blot analysis. If the introduced nucleic acid molecule according to the invention, or that is used according to the invention, is homologous with respect to the plant cell, the cells according to the invention can be distinguished from natural cells, for example, based on the additional expression of the nucleic acid molecules according to the invention, or which are used according to the invention. For example, transgenic plant cells contain more or less transcripts of the nucleic acid molecules according to the invention, or that are used according to the invention. This can be detected, for example, by analysis
^^ - ftj Northern blot. "More" or "less" in this context means preferably at least 10% more or less, preferably at least 20% more or less, and especially at least 50% more or less transcribed than the corresponding non-transformed cells. In addition, the cells preferably exhibit a corresponding increase or decrease in the protein content encoded by the nucleic acid molecules that have been introduced (at least 10%, 20% or 50%). The transgenic plant cells can be regenerated in whole plants by means of techniques known to those skilled in the art. The plants obtained by regenerating the transgenic plant cells according to the invention, and the methods for generating transgenic plants by regenerating whole plants of the plant cells according to the invention, are also subject of the present invention. Another subject of the invention are the plants that contain the transgenic plant cells according to the invention. In principle, the transgenic plants can be plants of any species, that is, not only monocotyledonous plants, but also dicotyledonous plants. Preferably, the plants are useful plants and starch storage plants such as, for example, cereal species (rye, barley, oats, corn, wheat, sorghum and millet, etc.), sago, rice, peas, large-seeded pea , yucca, potato, tomato, oilseed rape, soybean, hemp, flax, sunflower, cowpea, mungbean, or arrowroot.
The invention also relates to the propagation material of the plants according to the invention, for example, fruits, seeds, tubers, rhizomes, shoots, cuts, calluses, protoplasts, cell cultures, and the like. The alteration of the enzymatic activities of the enzymes involved in starch metabolism results in a starch of altered structure in the plants generated by the methods according to the invention. A large number of cloning vectors is available for
prepare the introduction of foreign genes in higher plants, vectors that contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells. Examples of such vectors are pBR322, the pUC series, the M13mp series, pACYC184, and the like. The desired sequences can be introduced into the vector at a cutting site of
adequate restriction. The obtained plasmid is used to transform E. coli cells. The transformed E. coli cells are grown in a suitable medium, and then harvested and lysed. The plasmid is recovered. The analytical methods to characterize the plasmid DNA obtained are generally restriction analysis, gel electrophoresis and other methods of
Biochemistry and Molecular Biology (Sambrook et al., In the aforementioned place). After each manipulation, the plasmid DNA can be cut and the DNA fragments obtained can be ligated with other DNA sequences.
> S? Fo? I &? T ila.-.
Each plasmid DNA sequence can be cloned in the same plasmid or in other plasmids. A large number of techniques are available to introduce DNA into a host plant cell. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformants, protoplast fusion by means of polyethylene glycol (PEG), injection, DNA electroporation, the introduction of DNA by the biolistic method, and other possibilities ("Gene Transfer to Plants", pages 24-29, eds: Potrykus I. and Spangenberg G., Springer Verlag Berlin Heidelberg 1995). The injection and electroporation of DNA in plant cells does not require particular aspects of the plasmids or the DNA used. Simple plasmids such as for example pUC derivatives can be used. However, if you are going to regenerate whole plants from these transformed cells, the presence of a selectable marker gene is required. Depending on the method of introduction of the desired genes into the plant cell, additional DNA sequences may be required. If, for example, the Ti or Ri plasmids are used to transform the plant cell, at least the right margin, but frequently both the right and left margins of the T-DNA of the Ti and Ri plasmids, must be linked to the genes that are they will introduce as a flanking region.
< . **. * # & * .. * If an agrobacteria is used for transformation, the DNA to be introduced must be cloned into specific plasmids, either in an intermediate vector or in a binary vector. The intermediate vectors can be integrated into the agrobacterial Ti or Ri plasmids by homologous recombination, due to sequences that are homologous to sequences in the T-DNA. The first also contains the vir region, which is required for the transfer of T-DNA. Intermediate vectors can not be replicated in agrobacteria. The intermediate vector can be transferred to Agrobacterium tumefaciens by means of a helper plasmid (conjugation). The vectors
binaries are capable of replicating in E. coli and in agrobacteria. They contain a selection marker gene and a linker or polylinker that is framed by the left and right margin regions of the T DNA. They can be directly transformed into the agrobacteria (Holsters et al. (1978) Mol. Gen. Genet. 163: 181- 187). The agrobacteria that acts as the cell
The host must contain a plasmid carrying a vir region. The vir region is required to transfer the T-DNA to the plant cell. Additional DNA T may be present. The transformed agrobacteria is used to transform plant cells. The use of T-DNA to transform plant cells has been
investigated extensively and described in EP 120516; Hoekema, in "The Binary Plant Vector System", Offserdrukkeerij Kanters B.V., Alblasserdam (1985) chapter V; Fraley et al., Crit. Rev. Plant Sci. 4: 1-46, and An et al. (1985) EMBO J. 4: 277-287.
- Sas * ^ it ~ To transfer the DNA to the plant cell, vegetable explants can be co-cultured with Agrobacterium tumefaciens or Agrobacterium rhizogenes. It is then possible to regenerate whole plants of the infected plant material (for example, leaf section, stem sections, roots, but also protoplasts or plant cells grown in suspension cultures) in a suitable medium which may contain, for example, antibiotics or biocides to select the transformed cells. The resulting plants can then be examined for the presence of the introduced DNA. Other possibilities of introducing foreign DNA using the biolistic method or by protoplast transformation are known (see, for example, Willmitzer L., 1993, "Transgenic plants" in "Biotechnology, a Multi-Volume Comprehensive Treatise" [Biotechnology]. , Comprehensive treatise on volumes] (HJ Rehm, G. Reed, A. Pühler, P. Stadler, eds.), Vol. 2, 627-659, VCH Weinheim-New York-Basel-Cambridge). Although the transformation of dicotyledonous plants by means of vector systems of Ti plasmid with the help of Agrobacterium tumefaciens is well established, a more recent work suggests that monocotyledonous plants are also really accessible for transformation by means of vectors based on agrobacteria (Chan and others, Plant Mol. Biol. 22 (1993), 491-506; Hiei et al., Plant J. 6 (1994), 271-282). Alternative systems for the transformation of monocotyledonous plants are the transformation by means of the biolistic method, protoplast transformation, the electroporation of partially permeabilized cells, and the introduction of DNA by means of glass fibers. Specifically different methods for the transformation of corn have been described in the literature (see for example WO 95/06128, EP 0 513 849, EP 0 465 875). EP 292 435 discloses a method by means of which fertile plants can be obtained starting from a granular corn husk, friable, free of mucus. In this context, Shillito et al. (Bio / Technology 7 (1989) 581) have observed that the regenerative capacity of fertile plants requires the production of suspended callus cultures, of which
can make a protoplast culture in division with the ability to regenerate plants. Prioli and Sóndahl (Bio / Technology 7 (1989), 589) also describes the regeneration and obtaining of fertile maize plants from maize protoplasts. Once the introduced DNA is integrated into the genome of the
The plant cell is generally stable therein and is also retained in the progeny of the originally transformed cell. It normally contains a selection marker that mediates the resistance of the transformed plant cells to a biocide or antibiotic such as kanamycin, G 418, bleomycin, hygromycin, phosphinotycin, and the like. Therefore, the marker
The chosen individual must allow the selection of the transformed cells on the cells lacking the introduced DNA. Within the plant, the transformed cells develop in the usual way (see also McCormick et al. (1986) Plant Cell
Reports 5: 81-84). The resulting plants can develop normally and hybridize with plants that have the same transformed germplasm or other germplasm. The resulting hybrids have the corresponding phenotypic characteristics. 5 Two or more generations must be developed to ensure that the phenotypic characteristic is retained and inherited in a stable manner. Also, seeds or the like must be harvested to ensure that the phenotype in question or other characteristics have been retained. Due to the expression of a nucleic acid molecule of
In accordance with the invention, the transgenic cells and plants according to the invention synthesize a starch whose properties, for example physicochemical properties, are altered in comparison with the starch synthesized in wild-type plants. A further subject of the invention is the starch that is obtained from a cell and plant of the invention, from its propagation material, or in accordance with a method of the invention. Another subject of the invention is a method of producing starch in a manner known per se, in which the host cells, plant cells, plants, and parts of plants according to the invention, or their propagation material, are processed or integrate in the method. In a preferred embodiment, the starch according to the invention is distinguished in that its phosphate content is reduced by at least 30%, preferably at least 50%, especially at least 70%, and
i-MJsife e ??? m * > • «^ s? ISJtt & tffet'g ^ .l áa-isfe * ^, á m HSkatieti * -.-? > 'very preferably at least 90%, compared to a starch obtainable from a non-transformed (ie, wild-type) cell or plant, and because its content of glucan (see fraction 3 in example 13), after treatment with isoamylase in the exclusion volume of a column HPLC system composed of 2 TSK-gel 2000SW columns connected in series and a TSK-gel 3000SW column in 10 mM sodium acetate, pH 3.0 (at a flow rate of 0.35 ml / min as shown in example 13), increases at least 50%, preferably at least 150%, especially at least 300%, and most preferably at least 500%. In a further embodiment, the starch according to the invention is distinguished in that its phosphate content increases by at least 10%, preferably at least 30%, and most preferably at least 50%, compared to a starch obtainable from a cell or plant not transformed (ie, wild-type), and because its content of glucan (see fraction 3 of Example 13), after treatment with amylase in the volume of exclusion of a HPLC system of column composed of TSK-gel 2000SW columns connected in series and a TSK-gel 3000SW column in 10 mM sodium acetate, pH 3.0 (at a flow rate of 0.35 ml / min as shown in example 13), increases at least 50% , preferably at least 150%, especially at least 300%, and most preferably at least 500%. Methods for extracting starch from plants or from starch storage organs of plants are known to those skilled in the art. For example, Eckhoff et al. Describe processes for extracting starch from corn kernels (Cereal Chem. 73 (1996) 54-57). As a rule, the extraction of maize starch on an industrial scale is carried out by means of wet milling. In addition, processes for extracting starch from a variety of starch storage plants are described, for example, in "Starch Chemistry and Technology" (Editors: Whistler, BeMiller and Paschall (1994)). 2nd Edition, Academic Press Inc. London Ltd; ISBN 0-12-746270-8; see, for example, chapter XII, pages 412-468, production of corn starches and sorghum: Watson; Chapter XIII, pages 469-479, production of tapioca starches, arrowroot and sago: Corbishley and Miller; Chapter XIV, pages 479-490, potato starch: production and uses: Mitch; chapter XV, pages 491 to 506, wheat starch: production, modification and uses: Knight and Oson; and chapter XVI, pages 507 to 528: production and uses of rice starch: Rohmer and KIem). The devices normally used to extract starch from plant material are separators, decanters, hydrocyclones, spray dryers and fluidized bed dryers. A further embodiment of the present invention also includes the use of the starch according to the invention in the industry, preferably for the production of food products, packaging materials or disposable products. The starch according to the invention can be modified chemically and / or physically by means of methods known to those skilled in the art, and is suitable in its modified or unmodified form for a variety of applications in the food or non-food sector. In principle, the possible uses of starch in accordance with the
invention can be divided into two important sectors. One sector covers the products of starch hydrolysis, mainly glucose and glucose units, which are obtained by chemical or enzymatic means. They are used as starting material for other chemical modifications and processes such as fermentation. What may be important here is simplicity and design
The cost of a hydrolysis process such as is generally carried out essentially enzymatically using amyloglucosidase. A financial savings would be feasible using less enzyme. This could be done by altering the structure of the starch, for example by increasing the surface area of the granule, improving its susceptibility to degradation by reducing the
degree of branching, or of a steric structure that limits the access of the enzymes used. The other sector in which the starch according to the invention can be used as a native starch due to its polymeric structure, can be divided into two additional fields of application: 1. The food industry Starch is a traditional additive for a large number of food products in which its function is essentially to agglutinate
aqueous additives or cause an increase in viscosity or increase the gelation. The important characteristics are the flow characteristics, the sorption characteristics, the swelling temperature, the gelatinization temperature, the viscosity, the thickening power, the solubility of the starch, the transparency, the structure of the gel, the thermal stability, the stability against shear stress, stability against acids, the tendency to undergo degradation, film forming capacity, freeze-thaw stability, susceptibility to digestion, and the ability to form complexes, for example, with ions inorganic or organic
2. The non-food industry In this important sector, starch is used as an auxiliary for various preparation processes or as a product additive. When starch is used as an auxiliary, mention should be made in particular of the paper and cardboard industry. Starch acts mainly for retarding purposes (retaining solids), agglutinating filler particles and fines, as a hardener and for dehydration. In addition, the advantageous properties of the starch with respect to rigidity, hardness, sound, touch, luster, softness, bond strength and surface treatment.
2. 1 Paper and cardboard industry Within the papermaking process, four fields must be distinguished, that is, surface treatment, coating, kneading and sprinkling. With 80% of the consumption, the starch for surface treatment usually represents the highest amount of starch, 8% is used as a coating starch, 7% as a kneading starch and 5% as a starch for aspersion. The demands on starch with respect to surface treatment are essentially high whiteness, an adapted viscosity, very stable viscosity, good film formation and little dusting. When used for coating, solid content, adequate viscosity, high agglutination capacity and high affinity of pigments play an important role. When used as a kneading additive, a fast, uniform and lossless distribution, high mechanical strength and complete retention on paper cloth is important. If the starch is used in the spraying sector, a suitable solids content, high viscosity and a high agglutination capacity are again of importance.
2. 2 The adhesives industry An important field of application of starches is in the adhesives industry, where potential uses can be divided into four subsections: use as a pure starch paste, use in starch pastes that they have been treated with special chemical agents, the use of starch as an additive for synthetic resins and polymer dispersions, and the use of starches as extenders for synthetic adhesives. 90% of the starch-based adhesives are used in the sectors of
* More corrugated cardboard, production of bags and paper bags, production of mixed materials for paper and aluminum, production of cardboard boxes and gummy adhesives for wraps, stamps and the like.
2. 3 Textile industry and textile care products industry An important field of application for starches as auxiliaries and additives is the production of textile products and products for the care of textile products. The following four fields of application should be distinguished within the textile industry: the use of starch as a sizing agent, that is, as an auxiliary to soften and reinforce the burning behavior as a protection of the tensile forces applied during weaving, and increase the resistance to abrasion during weaving; starch as a textile finishing agent, in particular after quality reducing pretreatments such as bleaching, dyeing and the like; starch as a thickener in the preparation of dye pastes to prevent dye exudation; and starch as an additive for warp agents for sewing threads. 2.4 Building materials industry
The fourth field of application is the use of starches as additives in building materials. An example is the production of gypsum boards, where the starch that is mixed with the gypsum suspension is gelatinized with water, and diffuses to the surface of the mortar core and joins the cardboard with the core. Other fields of application are the mixture for plaster and mineral fibers. In the case of ready mix concrete, starch products are used to retard hardening.
2. 5 Soil stabilization A limited market for starch products is the production of soil stabilizers, which are used to temporarily protect soil particles from water when it is artificially disturbed. According to current knowledge, the combination products of starch and polymer emulsions match the previously used products with respect to their erosion and scale-reducing effect, but they are notably less expensive.
2. 6 Use in crop and fertilizer protection products One field of application for using starch is in crop protection products to alter the specific properties of those products. In this way, the starches are used to improve the wetting capacity of crop protection products and fertilizers, for the dosed supply of active ingredients, to convert liquid active ingredients, volatile active ingredients and / or active ingredients of malodor, into conformable, stable, microcrystalline substances, to mix incompatible compounds and to prolong the duration of action by reducing their decomposition.
2. 7 Pharmaceutical, medicinal and cosmetic industry 5 Another field of application is the sector of the pharmaceutical, medicinal and cosmetic industry. In the pharmaceutical industry, starches are used as binders for tablets or to dilute the binder in capsules. In addition, starches are used as tablet disintegrants, since they absorb fluids after they have been
swallows, swelling in a short period to such an extent that the active ingredient is released. Medicinal lubricating powders and powder for wounds are made based on starch for quality reasons. In the cosmetic sector, starches are used, for example, as vehicles for powder additives such as fragrances and salicylic acid. A relatively applicable field
of the starch is that of toothpastes.
2. 8 Addition of coal starch and carbon agglomerates A field of application for starch is as an additive for coal and coal agglomerates. With the addition of starch, the coal can agglomerate or form into agglomerates, in terms of high quality, thus preventing the early decomposition of the agglomerates. In the case of charcoal for steak, the addition of starch reaches an amount between 4 and 6%; in the case of heated coal, between 0.1 and 0.5%. In addition,
These starches are becoming important as binders, since the emission of harmful substances can be markedly reduced when starches are added to charcoal and coal agglomerates.
2.9 Preparation of smoothed ore and coal sediment In addition, starch can be used as a flocculant in the preparation of smoothed ore and coal sediment.
2. 10 Casting Auxiliary 10 An additional field of application is as an additive for foundry auxiliaries. Several casting methods require cores made with sand treated with binders. The binder used predominantly until now is bentonite, which is treated with modified starches, in most cases inflatable starches. Purpose
to add the starch is to increase the fluidity and improve the agglutination power. In addition, the inflatable starches can meet other demands of production engineering, such as being dispersible in cold water, rehydratable and easily miscible with sand, and having high water binding capacity. 20 2.11 Use in the rubber industry Starch is used in the rubber industry to improve technical and visual quality. The reasons are the improvement of the luster of the
x ^^ t í¿ '^^ ^^ - surface, improved management and appearance; for this purpose, the starch is dispersed on the sticky rubberized surfaces of the rubber materials before cold curing; and also the improvement of the printing capacity in the rubber.
2. 12 Production of leather substitutes Modified starches can also be sold for the production of leather substitutes.
2. 13 Starch in synthetic polymers In the polymer sector, the following fields of application can be contemplated: the use of starch degradation products in the processes (the starch is only a filler, there is no direct link between the synthetic polymer and the starch) or, alternatively, the use of starch degradation products in the production of the polymers (the starch and the polymer form a stable bond). The use of starch as a pure filler is not competitive compared to other substances such as talc. However, this is different when the specific properties of the starch impact the spectrum of characteristics of the final products, significantly altering said spectrum. An example of this is the use of starch products in the treatment of thermoplastics such as polyethylene. Here, the starch and the synthetic polymer are combined by coexpression at a ratio of 1.1 to produce a master batch from which various products are made together with granulated polyethylene, using conventional treatment techniques. By using starch in polyethylene films, a greater permeability of substances can be achieved in the case of hollow bodies, a better water vapor permeability, a better antistatic behavior, a better anti-block behavior and a better printing capacity with aqueous inks . The current disadvantages refer to insufficient transparency, reduced tensile strength and reduced elasticity. Another possibility is the use of starch in polyurethane foams. By adapting the starch derivatives and by optimizing the process engineering, it is possible to control the reaction between synthetic polymers and the hydroxyl groups of the starches in a targeted manner. This results in polyurethane films having the following spectrum of properties, due to the use of starch: a reduced coefficient of heat expansion, a
reduced shrinkage behavior, improved depression-tension behavior, an increase in water vapor permeability without altering the incorporation of water, a reduced flammability, and a reduced final tensile strength, without drop formation of the combustible parts, halogen free and reduced aging. The disadvantages that still
there are a reduced printing capacity and a reduced impact resistance. Product development is currently no longer restricted to movies. Solid polymer products can also be prepared
such as pots, slabs and plates, with a starch content of more than 50%. In addition, starch / polymer mixtures are considered advantageous since their biodegradability is much higher. Starch graft polymers have become increasingly important due to their extremely high water binding capacity. They are products with a skeleton of starch and a side chain of a synthetic monomer, grafted following the principle of chain mechanism of free radicals. The currently available starch graft polymers are distinguished by a better water binding and retention capacity of up to 1000 g of water per g of starch combined with high viscosity. The fields of application for these superabsorbents have been widespread in recent years and are, in the hygiene sector, the products of diapers and pads, and in the agricultural sector, for example seed coatings. What is decisive for the application of novel starches constructed by genetic engineering, is on the one hand the structure, water content, protein content, lipid content, fiber content, ash / phosphate content, amylose / amylopectin ratio, distribution of molecular mass, degree of branching, size and shape of granule, and crystallization; and on the other hand, also the characteristics that affect the following characteristics: flow and sorption behavior, gelatinization temperature, viscosity, thickening power, solubility, gel structure, transparency, heat stability, shear stability, stability to acids , tendency to undergo degradation, gel formation, freeze-thaw stability, complex formation, iodine binding, film formation, adhesive power, stability to enzymes, digestion capacity and reactivity. The production of modified starches by means of genetic engineering can, on the one hand, alter, for example, the properties of the starch derived from the plant, in such a way that no further modification is required by means of chemical or physical alterations. On the other hand, starches that have been altered by genetic engineering can be subjected to
to additional chemical modification, which leads to quality improvements for some of the fields of application mentioned above. These chemical modifications are known in principle. In particular, they are modifications by treatment with heat and pressure, treatment with organic or inorganic acids, enzymatic treatment, oxidations or
esterifications leading, for example, to the formation of phosphate starches, nitrate starches, sulfate starches, xanthan starches, acetate starches and citrate starches. In addition, monohydric or polyhydric alcohols can be used in the presence of strong acids to prepare starch ethers, resulting in alkyl ethers, o-allylethers,
starchy hydroxyalkylether and O-carboxylmethyl ethers, starch ethers containing N, S-containing starch ethers, cross-linked starches or starch graft polymers.
One use of the starches according to the invention is the industrial application, preferably for food products or for the preparation of packaging materials and disposable articles. The following examples serve to illustrate the invention and do not constitute a restriction in any way.
Abbreviations: BE branching enzyme bp base pairs 10 GBSS granulated beta-linked starch synthase IPTG isopropyl- -D-thiogalactopyranoside soluble starch synthetase PMSF phenylmethylsulfonyl fluoride
Means and solutions used in the examples: SSC 20x 175.3 g NaCI 88.2 g sodium citrate up to 1000 ml with double distilled water pH 7.0 with 10 N NaOH Shock absorber A 50 mM Tris-HCl pH 8.0 DTT 2.5 mM
EDTA 2 mM PMSF 0.4 mM glycerol 10% sodium dithionite 0.1% Shock absorber B Tris-HCl 50 mM pH 7.6 DTT 2.5 mM EDTA 2 mM Shock absorber C sodium citrate 0.5 M pH 7.6 Tris-HCl 50 mM pH 7.6 DTT 2.5 mM EDTA 2 mM TBS 10x Tris-HCl 0.2 M pH 7.5 NaCl 5.0 M TBST IOx TBS 10x Tween 20, 0.1% (v / v) Elution buffer Tris 25 mM pH 8.3 glycine 250 mM Dialysis buffer Tris-HCl 50 mM pH 7.0 NaCl 50 mM 2 mM EDTA-14.7 mM mercaptoethanol 0.5 mM PMSF Protein buffer 50 mM sodium phosphate buffer pH 7.2% 10 mM EDTA 0.5 mM PMSF-14.7 mM mercaptoethanol
DESCRIPTION OF THE FIGURES
Figure 1 represents a schematic profile of RVA temperature (viscosity and temperature versus time [min]), this with the viscometer parameters T = gelatinization temperature, temperature at the beginning of gelatinization; Max specifies the maximum viscosity; Min specifies the minimum viscosity; End specifies the viscosity at the end of the measurement; Set is the difference (D) between Min and End (backspace). Figure 2 shows the side chain distribution of the determined amylopectin samples, on the right by means of HPAEC-PAC (voltage [mV] against Time [min]) and on the left determined by gel penetration chromatography (stream [nC] ] against Time [min]). A = control (wild type No. 1); B = (asSSIl, No. 7); C = (asSSIII, No. 8); D = (asSSIl asSSIII, No. 13); E = (asSSIl asSSIII, No. 14). The numbers given in square brackets in the description of the figures, refer to the numbers of the starch samples that are described in tables 1 and 2. The following methods were used in the examples:
yes? t & mjM iSÉ .A * »~» ~ - »¿* > 1. Cloning method The vector pBluescript II SK (Stratagene) was used for cloning in E. coli. For the transformation of plants, constructs of 5 genes were cloned into the binary vector pBinAR Hyg (Hófgen &Willmitzer, 1990, Plant Sci. 66: 221-230) and pBinB33-Hyg.
2. Bacterial strains and plasmids E. coli strain DH5a (Bethesda Research 10 Laboratories, Gaithersburg, E.U.A.) was used for the Bluescrpt pBluescript II KS vector (Stratagene) and for the pBINAR Hyg and pBinB33 Hyg constructs. E. coli strain XL1-Blue was used for excision in vivo.
pBinAR 15 Plasmid pBinAR is a derivative of the binary vector plasmid pBin19 (Bevan, 1984), which was constructed as follows: A fragment of 529 bp was isolated spanning nucleotides 6909-7437 of the 35S promoter of cauliflower mosaic virus from plasmid pDH51, as an EcoRI / Kpnl fragment (Pietrzak et al., 1986); HE
ligated between the EcoRI and Kpnl cleavage sites of the polylinker pUC18, and was named plasmid pUC18-35S. With the aid of the restriction endonucleases Hindlll and Pvull, a 192 bp fragment was isolated from plasmid pAGV40 (Herrera-Estrella et al., 1983), which covers DNA from the Ti plasmid
j < -fe »jm4A &? bñt0BS * tt¿S? & K & amp; t > '"J * pTiACHd (Gielen et al., 1984, nucleotides 11749-11939). After having provided the Pvull cut site with Sphl linkers, the fragment was ligated between the Sphl and Hindlll cut sites of pUC18-35S, and this was called pA7 plasmid. In addition, all the polylinker comprising the 35S promoter and the oes terminator was cut with EcoRI and HindIII and ligated into the pBin19 cut appropriately. This produced the plant expression vector pBinAR (Hófgen and Wíllmitzer, 1990). pBinB33 The promoter of the B33 gene of patatin Solanum tuberosum (RóchaSosa et al., 1989) was ligated, as a Dral fragment (nucleotides -1512- + 14) into the vector pUC19 cut with Sstl, which had been shaved at its ends with the T4 DNA polymerase help. This yielded the plasmid pUC19-B33. The B33 promoter was cut from this plasmid with EcoRI and Smal and ligated into the pBinAR vector cut suitably. This produced the plant expression vector pBinB33. pBinAr-Hyg Starting from plasmid pA7 (see description of pBinAR vector), the EcoRI-HindIII fragment comprising the 35S promoter, the oes terminator and the polylinker portion between the 35S promoter and the oes terminator, was introduced into the pBin-Hyg plasmid cut properly. pBinB33-Hyg Starting from the plasmid pBinB33, the EcoRI-HindIII fragment comprising the B33 promoter, part of the polyslinker and the terminator oes, is
cut and ligated into the pBin-Hyg vector cut properly. This produced the plant expression vector pBinB33-Hyg.
3. Transformation of Agrobacterium tumefaciens The DNA was transferred by direct transformation following the method of Hoffgen and Willmitzer (1988, Nucleic Acids Res. 16: 9877). The plasmid DNA of the transformed agrobacteria was isolated following the method of Birnboim and Doly (1979, Nucleic Acids Res. 7: 1513-1523), subjected to suitable restriction cut, and then analyzed by gel electrophoresis.
4. Transformation of potatoes The plasmids were transformed into potato plants (Solanum tuberosum L. cv. Desiree, Vereinigte Saatzuchten eG, Ebstorf) with the help of the C58C1 strain of Agrobacterium tumefaciens (Díetze et al. (1995) in "Gene Transfer to Plants "[Transfer of genes to plants], pages 24-29, editors: Potrykus I. and Spangenberg G., Springer Verlag, Deblaere et al., 1985, Nucí Acids Res. 13: 4777-4788). Ten small leaves of a sterile potato culture that had been cut with a scalpel were placed in 10 ml of an MS medium (Murashige and Skoog (1962) Physiol. Plant 15: 473) supplemented with 2% sucrose and containing 50 ml of a culture of Agrobacterium tumefaciens developed during the night under selection conditions. After gently shaking the culture for 3-5 minutes, it was incubated two more days in the dark. For callus induction, the leaves were then placed on MS medium supplemented with 1.6% glucose, naphtylacetic acid 5 mg / l, benzyllaminopurine 0.2 mg / l, claforan 250 mg / l, kanamycin 50 mg / l and Bactoagar 0.80%. After incubating the leaves for one week at 25 ° C and 3000 Lux, they were placed in MS medium supplemented with 1.6% glucose, zeatin ribose 1.4 mg / l, naphthylacetic acid 20 mg / l, gibberellic acid 20 mg / l, claforan 250 mg / l, kanamycin 50 mg / l and Bactoagar 0.80%, to induce rods.
. Plant cultivation regime Potato plants were stored in a greenhouse under the following regime: Light period 16 hours at 25,000 Lux and 22 ° C Dark period 8 hours at 15 ° C Atmospheric humidity 60%
6. Radioactive labeling of the DNA fragments The DNA fragments were radiolabelled with the help of a "DNA Random Primer Labeling" labeling equipment from Boehringer Mannheim (Germany) following the manufacturer's instructions.
7. Determination of the activity of starch synthetase The determination of starch synthetase activity was done by determining the incorporation of 14C-glucose of ADP [14C-glucose] into an insoluble methanol / KCl product as described by Denver and Smith, 1992, Plant 186: 609 -617. 5 8. Detection of soluble starch synthase in the native gel To detect the activity of soluble starch synthetases by non-denaturing gel electrophoresis, tissue samples of potato tubers were hydrolyzed in 50 mM Tris-HCl pH 7.6, 2 mM DTT, EDTA 2.5 mM, 0 glycerol 10% and 0.4 mM PMSF. Electrophoresis was carried out in a MíniProtean II chamber (BioRAD). The monomer concentration in the 1.5 mm thick gels was 7.5% (w / v), and 25 mM Tris-glycine pH 8.4 was used as buffer for the gel and buffer for the run. Identical amounts of protein extract were applied, and separation was carried out for 2 5 hours at 10 mA per gel. Gels with activity were subsequently incubated in 50 mM Tricine-NaOH pH 8.5, 25 mM potassium acetate, 2 mM EDTA, 2 mM DTT, 1 mM ADP-glucose, 0.1% amylopectin (w / v) and 0.5 M sodium citrate. The formed glucans were stained with Lugol's solution. 0 9. Starch analysis The starch formed by the transgenic potato plants was characterized by the following methods:
(a) Determination of the amylose / amylopectin ratio in the starch of potato plants. Starch was isolated from potato plants by means of normal methods, and the amylose: amylopectin ratio was determined by the method described by Hovenkamp-Hermelink et al. (Potato Research 31 (1988) 241-246). (b) Determination of phosphate content in potato starch, some glucose units can be phosphorylated on carbon atoms at positions C2, C3 and C6. To determine the degree of phosphorylation at the C6 position of glucose, 100 mg of starch was hydrolysed for 4 hours at 95 ° C in 1 ml of 0.7 M HCl (Nielsen et al. (1994) Plant Physiol. 105: 1 11-1 17). After neutralization with 0.7 M KOH, 50 ml of the hydrolyzate was subjected to a visual-enzymatic test to determine glucose-6-phosphate. The absorption change of the test batch (imidazole 100 mM / HCl) was monitored; 10 mM MgCl 2; NAD 0.4 mM; 2 units of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides; 30 ° C) at 334 nm. Total phosphate was determined as described by Ames, 1996, Methods in Enzymology VIII, 115-118. (c) Analysis of the amylopectin side chains To analyze the distribution and length of the side chains in the starch samples, 1 ml of a 0.1% starch solution was digested with 0.4 U of soamilasa (Megazyme International Ireland Ltd. , Bray, Ireland)
s * overnight at 37 ° C in a 100 mM sodium citrate buffer, pH 3.5. The rest of the analysis was carried out as described by Tomlinson et al. (1997), Plant J. 11: 31-47, unless otherwise specified. (d) Determination of granule size The granule size was determined using a "Lumosed" photosedimentometer from Retsch GmbH, Germany. For this purpose, 0.2 g of starch was suspended in approximately 150 ml of water and measured immediately. The program supplied by the manufacturer calculated the average diameter of the starch granules, assuming an average starch density of 1.5 g / l. (e) Gelatinization properties The gelatinization or viscosity properties of the starch were recorded using a Vískograph E viscometer from Brabender OHG, Germany, or using a Rapid Visco Anayzer from Newport Scientific Pty Ltd., Investment Support Group, Warriewood NSW 2102, Australia. When Viskograph E is used, a suspension of 20 g of starch in 450 ml of water is subjected to the following heating program: heat at 3 min from 50 ° C to 96 ° C, keep constant 30 minutes, cool to 3 min up to 30 ° C, and again keep constant for 30 minutes. The temperature profile gave the characteristic properties of gelatinization. When measured using the Rapid Visco Analyzer (RVA), a suspension of 2 g of starch in 25 ml of water was subjected to the following heating program: suspend for 60 seconds at 50 ° C, heat at 12 min at 50 ° C at 95 ° C, keep constant for 2.5 minutes, cool to
12 ° C / min up to 50 ° C, and again keep constant for 2 minutes. The RVA temperature profile gave the viscometric parameters of the test starches for maximum viscosity (Max), final viscosity (End), gelatinization temperature (T), the minimum viscosity (Min) that occurs after the maximum viscosity, and the difference between the minimum and final viscosity
(setback, Set) (see table 1 and figure 1). (f) Determination of the strength of the gel To determine the strength of the gel by means of an analyzer
Texture Analyzer, 2 g of starch were gelatinized in 25 ml of water (see RVA measurement) and then stored for 24 hours in a sealed container at 25 ° C with the exclusion of air. Samples were mounted under the probe (circular seal) of a TA-XT2 Texture Analyzer (Stable Micro Systems), and gel strength was determined with the following parameter values: Test speed 0.5 mm Penetration depth 7 mm Contact area (of the seal) 1 13 mm2 Pressure / contact area 2 g
. Determination of glucose, fructose and sucrose To determine the content of glucose, fructose and sucrose, small portions of potato tuber (approximately 10 mm in diameter) were frozen in liquid nitrogen, and then extracted for 30 minutes at 80 ° C in 0.5 ml of 10 mM HEPES, pH7.5; 80% ethanol (vol / vol). The supernatant, which contains the soluble materials, was removed and the volume determined. The supernatant was used to determine the amount of soluble sugars. The quantitative determination of glucose, fructose and sucrose soluble in a batch with the following composition was carried out:
100. 0 mM midazole / HCI, pH 6.9 1.5 mM MgCl2 0.5 mM NADP + 1.3 mM ATP 10-50 I sample 1.0 unit of yeast glucose-6-phosphate dehydrogenase
The batch was incubated for 5 minutes at room temperature. Subsequently, the sugars were determined by photometry by measuring the absorption at 340 nm after the successive addition of:
1. 0 unit of yeast hexokinase (to determine glucose) 1.0 unit of yeast phosphoglucoisomerase (to determine fructose) and 1.0 unit of yeast invertase (to determine sucrose)
11. Determination of water incorporation capacity
(WUC) To determine the water incorporation capacity, soluble material was removed from the starch that had been swollen at 70 ° C, by means of centrifugation (10 minutes at 10,000 x g), and then the residue was weighed. The water incorporation capacity of the starch was based on the initial amount of starch corrected by the soluble material. WUC (g / g) = (residue- (initial amount-soluble) / (initial quantity-soluble)
EXAMPLES OF USE
EXAMPLE 1 Preparation of plasmid p35S SSI-Hyg
An Asp718 / Xbal fragment of 1831 bp containing a partial cDNA coding for potato SS I (Abel G. 81995), thesis for PhD, Freie Universitát Berlin), between Asp718 and the Xbal cut site of the vector pBinAR- was introduced. Hyg in antisense orientation with respect to the 35S promoter.
? * gjgfó EXAMPLE 2 Preparation of plasmid p35S-SSI-Kan
A 2384 bp EcoRI fragment containing cDNA coding for potato SS I was shaved at its ends (Abel, 1995, in the aforementioned place), and was introduced into the vector pBinAR, which had previously been cut with Smal, in orientation of meaning with respect to the 35S promoter.
EXAMPLE 3 Preparation of plasmid p35S SSII-Kan
A 1959 bp Smal / Asp718 fragment containing a partial cDNA encoding SSII from potato was shaved at its ends (Abel, 1995, called GBSS II therein), and introduced into the Smal cut site of the pBinAR vector in antisense orientation with respect to the 35S promoter.
EXAMPLE 4 Preparation of Plasmid pB33-SSII-Hvq
0 A Smal / Sall fragment of 2619 bp containing a
CDNA coding for potato SS II (Abel, 1995, in the aforementioned place) in the vector pBinB33-Hyg, which had previously been cut with Smal and Sali, in sense orientation with respect to the B33 promoter.
• ^ ^ - ^ & ^ a EXAMPLE 5 Preparation of plasmid p35S SSIII-Hyq
An Asp718 / Xbal fragment of 4212 bp containing a cDNA encoding the SS III of potato (Abel et al., 1996, Plant J. 10 (6): 981-991) was inserted between the ASP718 and the Xbal cut site. vector pBinAR-Hyg, in antisense orientation with respect to the 35S promoter.
EXAMPLE 6 Preparation of plasmid p35S-SSIII-Kan
An EcoRI fragment of 4191 bp containing a cDNA encoding the SS III of potato was shaved at its ends (Abel et al., 1996, in the aforementioned place), and was introduced into the Smal cut site of the vector pBinAR in orientation of meaning with respect to the 35S promoter.
EXAMPLE 7 Preparation of Plasmid pB33 BE SSIII-Kan
A 1650 bp Hindlll fragment containing a partial cDNA encoding potato BE enzyme was shaved at its ends (Kossman et al., 1991, Mol. &Gen. Genetics 230 (1-2): 39-44), and it was introduced into the pBinB33 vector that had previously been cut with Smal, in antisense orientation with respect to the B33 promoter. The resulting plasmid was opened by cutting with BamHI. At the cut site, a 1362 bp BamHI fragment containing a partial cDNA encoding the potato SS III enzyme was introduced (Abel et al., 1996, in the cited place), again in antisense orientation with respect to the promoter. B33.
EXAMPLE 8 Preparation of plasmid p35S SSII-SSIII-Kan
An EcoRV / Hincll fragment of 1546 bp, which contained a partial cDNA coding for the SS II of potato (Abel, 1995, in the aforementioned place), was cloned into the vector pBluescript II KS, which had been cut with EcoRV / Híncll, was then excised by a Asp718 / BamHI digestion and introduced in antisense orientation with respect to the 35S promoter in the vector
POINTS that had been digested in the same way. Then, a 1356 bp BamHI fragment containing a partial cDNA encoding potato SS III (Abel et al., 1996, in the aforementioned place) was introduced at the BamHI cleavage site of the vector pBinAR-SSI1, again in the orientation of antisense with respect to the 35S promoter.
EXAMPLE 9 Preparation of Plasmid pB33 SSl SSIII-Kan
A 2384 bp EcoRI fragment containing a cDNA coding for SS I from potato was shaved at its ends (Abel, 1995, in the cited place), and was cloned into the Smal cut site of the pBinB33 vector in antisense orientation. with respect to the B33 promoter. A 1362 bp BamHI fragment containing a partial cDNA coding for potato SS III (Abel et al., 1996, in the above-mentioned place) was introduced at the BamHI cleavage site of the resulting vector, again in antisense orientation with with respect to the B33 promoter.
EXAMPLE 10 Preparation of plasmid p35S SSII-Hyq 15 A 1959 bp Smal / Asp718 fragment containing a partial cDNA coding for SS II (Abel, 1995, in the aforementioned place) was shaved at its ends and introduced into the Smal cut site of the pBinAR-Hyg vector in antisense orientation with respect to the 35S promoter.
~ w && > s & * Si- -a ^ ** s ^ m§ & amp; amp; ~ '~ EXAMPLE 10B Preparation of Plasmid pB33 R1-Hyq
A 1.9 kB R1 fragment of S. tuberosum was obtained (WO
97/11188) by digestion with Asp718 of the pBluescript vector. The fragment was cloned into the Asp718 cut site behind the B33 promoter in antisense orientation of vector pB33-Binar-Hyg. This vector contains a resistance to hygromycin.
EXAMPLE 11 Introduction of plasmids in the qenoma of potato cells
The plasmids given in Examples 1 to 10 were transferred to agrobacteria, individually and / or in succession, with the aid of which, the
potato cells were transformed as described above. Subsequently, whole plants of the transformed plant cells were regenerated. Transgenic plants of the genotype asSSI-asSSII-asSSIII were generated by transformation with the plasmid p35S SSI-Hyg described in Example 1, and subsequent transformation with the plasmid p35S SSII-SSIII-Kan described in example 8. Transgenic plants of the genotype were generated. genotype asSSII-asSSI- asSSIII by transformation with the plasmid p35S SSII-Hyg described in
^^ m ^ ^ ^^ ^^^^^ a ^^ i example 10, and subsequent transformation with the plasmid pB33 SSl SSIII-Kan described in example 9. As a result of the transformation, the transgenic potato plants synthesized varieties of altered starch.
EXAMPLE 12 Physicochemical characterization of modified starches
The starch formed by the transgenic plants generated according to example 11, differs from the starch synthesized by wild-type (potato) plants for example, with respect to their phosphate or amylose content and the viscosities and gelatinization properties, which were determined by RVA Table 1 shows the results of the physicochemical characterization of the modified starches. In the antisense constructs, the enzymatic activities of the suppressed soluble starch synthetases were reduced by up to 85% with respect to the untransformed control plants.
^^^ ^^ ^^ ¿^^ PICTURE, 1
Properties of modified starches TABLE 1 (continued)
Keys: SS1 = isoform I of starch synthetase; SSII = sophorm II of starch synthetase; SSIII = isoform III of starch synthetase; BE = branching enzyme; as = antisense; oe = overexpressed (sense); cos = cosuprimido (sense); data of the Rapid Visco Analyzer (RVA): max designates the maximum viscosity; min the minimum viscosity; end the viscosity at the end of the measurement; set is the difference (D) between min and end (recoil) and T is the temperature of gelatinization. The percentages are based on the wild type (= 100%).
& & js ¿j¡sß ~ ** 3t * m * ~. .. "^ ^ - Ba-aii EXAMPLE 13 Characterization of the side chains of modified starches
The glucan chains were separated after removing the amylose by means of thymol precipitation (Tomlinson et al., In the cited place), using a high performance anion exchange chromatography system with an amperometric detector (HPEAC-PAD, Dionex) . The samples (10 mg / ml amylopectin) were dissolved in 40% DMSO and 1/10 part by volume of 100 mM sodium acetate pH 3.5, and 0.4 U of soamilase (Megazyme) were added. After incubation, 10 μl of the sample was applied to the column system and eluted as described by Tomlinson and others (in the cited place). Figure 2 shows the results of the HPEAC-PAD analysis regarding the length and distribution of the side chains of the starch samples Nos. 1, 7, 8, 13 and 14 (see tables 1 and 2). Another HPLC system to detect the side chain distribution, consisted of 3 columns connected in series (2 TSK-Gel 2000SW and one TSK-Gel 3000SW, TosoHaas, Stuttgart, Germany) as described by Hizukuri ((1986) Carbohydr, Res. 147: 342-347). 100 I of the prepared sample was applied to the column system. The eluent used was 10 mM sodium acetate, pH 3.0, at a flow rate of 0.35 ml / min. The glucans were detected by means of a refractive index detector (Gynkotek), and the chain lengths of linear eluted glycans were
t ^ - _ .Arflir .m. t '«K? J determined by means of mass spectroscopy and iodometry (Hizukuri (1986), in the cited place). Figure 2 shows the results of the gel-chromatographic analysis of HPLC, with respect to length and distribution of the side chains of starch samples Nos. 1, 7, 8, 13 and 14 (see tables 1 and 2) . Table 2 shows the percentages of several side chain fractions of the starches that were analyzed. Fraction 1 represents the percentage of the A and B1 chains (Hízukuri (1986), in the aforementioned place); fraction 2 represents the percentage of chains B2, B3 and B4 (Hizukuri (1986), in the aforementioned place); and fraction 3 shows the percentage of the high molecular weight glucan molecules eluting in the elution volume. TABLE 2 Distribution of amylopectin side chains of modified starch
Go ¿¿S -.Sfefl.
Claims (30)
1. - A method for the preparation of a transgenic host cell, characterized in that they are integrated into the genome of a cell simultaneously or sequentially, (a) at least one nucleotide sequence that encodes a protein with the function of a starch synthetase soluble III, or fragments of said nucleotide sequence, and (b) one or more nucleotide sequences that encode a protein selected from group A, consisting of proteins that function as branching enzymes, ADP glucose pyrophosphorylases, bound starch synthetases to granule, soluble starch synthetases, debranching enzymes, disproportionate enzymes, plastid starch phosphorylases, R1 enzymes, amylases and glycosidases, or fragments thereof.
2. The method according to claim 1, wherein the cell is a bacterial or plant cell.
3. A transgenic host cell, comprising (a) at least one nucleotide sequence encoding a protein having the function of a soluble starch synthetase III, or fragments of said nucleotide sequence, and (b) a more nucleotide sequences encoding a protein selected from group A, consisting of proteins that have the function of branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases, debranching enzymes, disproportionate enzymes, starch phosphorylases of plastids, R1 enzymes, amylases and glucosidases, or fragments thereof.
4. The host cell according to claim 3, further characterized in that it is a bacterial or plant cell.
5. A recombinant nucleic acid molecule, comprising (a) at least one nucleotide sequence encoding a protein having the function of a soluble starch synthetase III, or fragments of said nucleotide sequence, and (b) one or more nucleotide sequences encoding a protein selected from group A, consisting of proteins having the function of branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases, debranching enzymes, disproportioning enzymes, phosphorylases of plast starch, R1 enzymes, amylases and glucosidases, or fragments thereof.
6. The nucleic acid molecule according to claim 5, further characterized in that it is a molecule of deoxyribonucleic acid.
7. The nucleic acid molecule according to claim 6, further characterized in that it is a cDNA molecule.
8. The nucleic acid molecule according to claim 5, further characterized in that it is a ribonucleic acid molecule.
9. - A nucleic acid molecule that hybridizes specifically with a nucleic acid molecule as claimed in one or more of claims 5 to 8.
10. A vector comprising a nucleic acid molecule 5 as claimed in one or more of claims 5-9.
11. A vector comprising a nucleic acid molecule as claimed in one or more of claims 5-9, characterized in that the nucleotide sequence encoding a protein having the function of a soluble starch synthase, or fragments of the 10 itself, it is present in sense or antisense orientation.
12. A vector comprising a nucleic acid molecule as claimed in one or more of claims 5-9, characterized in that the nucleotide sequence encoding one or more proteins selected from group A, or fragments thereof , it is present 15 in sense orientation or antisense.
13. A vector comprising a nucleic acid molecule as claimed in one or more of claims 5-9, characterized in that the nucleotide sequence encoding one or more proteins selected from group A, or fragments thereof , is partially present in sense orientation and partially in antisense orientation.
14. A vector comprising a nucleic acid molecule as claimed in one or more of claims 5-9, which is linked to one or more regulatory elements that ensure the transcription and synthesis of an RNA in a prokaryotic or eukaryotic cell.
15. The method according to one or more of claims 1 and 2, further characterized in that one or more nucleic acid molecules as claimed in one or more of the claims are integrated into the genome of a cell. -9, or one or more vectors as claimed in one or more of claims 10-14.
16. The host cell according to one or more of claims 3 and 4, further characterized in that it contains one or more nucleic acid molecules as claimed in one or more of claims 5-9, or one or more vectors as claimed in one or more of claims 10-14.
17. A method of generating a transgenic plant that synthesizes a modified starch, characterized in that a whole plant of a plant cell is regenerated as claimed in one or more of claims 3, 4 and 16.
18.- One plant comprising one or more cells as claimed in one or more of claims 3, 4 and 16.
19. The plant according to claim 18, further characterized in that it is a starch storage plant.
20. The plant according to claim 19, further characterized in that it is a utility plant.
21. - The plant according to one or more of claims 18-20, further characterized because it is a wheat, corn, potato or rice plant.
22. The propagation material of a plant as claimed in one or more of claims 18-21.
23. A process for the preparation of starch by means of a method known per se, characterized in that the cells claimed in one or more of claims 3, 4 and 16, the plants claimed in the claim, are integrated into the process. one or more of claims 18-21, or the propagation material claimed in claim 22.
24.- A starch that can be obtained from a cell as claimed in one or more of claims 3, 4. and 16, a plant as claimed in one or more of claims 18-21, or of the propagation material claimed in claim 22.
25.- The starch according to claim 24, further characterized by having , compared to a starch obtained from a non-transformed plant or cell, a phosphate content reduced by at least 30%, and a glucan content after treatment with isoamylase in the elution volume of a colu system HPLC mna, composed of 2 columns TSK-Gel 2000SW and one column TSK-Gel 3000SW connected in series in 10 mM sodium acetate pH 3.0, which is increased by at least 50%.
26. - The starch according to claim 24, further characterized in that it has, compared to a starch obtained from a non-transformed plant or cell, a phosphate content increased by at least 10%, and a content of glucan after treatment with isoamylase in the elution volume of an HPLC column system, composed of 2 columns TSK-Gel 2000SW and one column TSK-Gel 3000SW connected in series in 10 mM sodium acetate pH 3.0, which is increased at least in fifty%.
27. The use of a starch as claimed in one or more of claims 24-26, in the industry, preferably for the production of food products, packaging materials or disposable articles.
28. The use of (a) at least one nucleotide sequence that encodes a protein that has the function of a soluble starch synthase III, or fragments of said nucleotide sequence, and (b) one or more nucleotide sequences encoding a protein selected from group A, consisting of proteins that function as branching enzymes, ADP glucose pyrophosphorylases, synthetases of granule-bound starch, soluble starch synthetases I, II or others, debranching enzymes, disproportionate enzymes, phosphorylases of plastid starch, R1 enzymes, amylases and glycosidases, or fragments thereof; for the production of transgenic cells, preferably bacterial or plant cells. • i * v
29. - The use of one or more nucleic acid molecules as claimed in one or more of claims 5-9, or of one or more vectors as claimed in one or more of claims 10-14, for the generation of transgenic cells, preferably bacterial or plant cells.
30. The use of the cells claimed in one or more of claims 3, 4 and 16, of the plants claimed in one or more of claims 18-21, or of the propagation material claimed in Claim 22, for the production of starch.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19836098.3 | 1998-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01001148A true MXPA01001148A (en) | 2001-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772364B2 (en) | Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch | |
US6791010B1 (en) | Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications | |
AU770735B2 (en) | Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch | |
US6940001B1 (en) | Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein | |
JP4148964B2 (en) | DNA molecules encoding enzymes involved in starch synthesis, and vectors, bacteria, transgenic plant cells and transgenic plants containing the DNA molecules | |
JP4538408B2 (en) | Plant cells and plants that synthesize starch with high final viscosity | |
US7112718B2 (en) | Transgenic plants synthesizing high amylose starch | |
CA2378173C (en) | Nucleic acid molecules from plants encoding enzymes which participate in starch synthesis | |
US6890732B1 (en) | Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch | |
US7989616B2 (en) | High-phosphate starch | |
MXPA01001148A (en) | Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch | |
CZ2001379A3 (en) | Plants synthesizing modified starch, processes for obtaining such plants, their use and modified starch | |
AU2002316971C1 (en) | Transgenic plants synthesising high amylose starch | |
AU2002316971A1 (en) | Transgenic plants synthesising high amylose starch |